Anlon Healthcare Limited — Results, 30-07-2026: Integrated Filing- Financial

Anlon Healthcare Limited has announced a board meeting to consider the financial results for the quarter and half-year ending June 30, 2026. The company is also pursuing an acquisition of 32.52% in Apiqo Organics Private Limited and 43.33% in Bizotic LifeScience Private Limited, aiming to make them wholly-owned subsidiaries through a share swap arrangement.

**1. Financial Performance (Consolidated):**

- Revenue from Operations: Rs. 8,756.27 Cr

- Total Income: Rs. 8,762.23 Cr

- Year-on-Year growth in revenue is substantial, driven by increased operational scale.

**2. Profitability and EPS:**

- Profit after tax: Rs. 828.14 Cr

- Basic EPS: Rs. 0.16

- Profitability saw a dip compared to the previous quarter, primarily due to a significant increase in the cost of materials consumed.

**3. Growth Drivers & Expense Trends:**

- Revenue growth in the consolidated segment appears robust.

- Key expenses like "Cost of materials consumed" and "Depreciation and amortization expense" have increased substantially in the consolidated segment compared to the previous quarter.

**4. Final Lens for Investors:**

The results show strong revenue growth but a notable contraction in profitability this quarter, warranting a closer look at cost management.